A First in Man, Phase I, Single-blind, Placebo-controlled Study Investigating the Local Tolerability, Safety and Pharmacokinetics in Three Doses of PXL01 and Placebo in 15 Healthy Volunteers
The main purpose of this study is to determine whether three different single doses of PXL01 are safe and well tolerated by healthy volunteers. The pharmacokinetic properties of PXL01 (same doses) will also be investigated.
100 Clinical Results associated with PharmaSurgics In Sweden AB
0 Patents (Medical) associated with PharmaSurgics In Sweden AB
100 Deals associated with PharmaSurgics In Sweden AB
100 Translational Medicine associated with PharmaSurgics In Sweden AB